Birla Institute of Technology, Mesra
   
Dr. Saurabh M. Verma
Professor, Pharmaceutical Sciences and Tech
Ph.D., M. Pharm., FIC, FICS
Contact Address
Permanent Address Deptartment of Pharmaceutical Sci. & Tech., Birla Institute of Technology, Mesra, Ranchi -835215, Jharkhand, India
Local Address Deptartment of Pharmaceutical Sci. & Tech., Birla Institute of Technology, Mesra, Ranchi -835215, Jharkhand, India
Phone (Office) 06512275444
Phone Residence 9534047294
Email Id smverma@bitmesra.ac.in
Joined Institute on : 17-Aug-1990
  Work Experience
 
Teaching : 32 Years

Research : 32 Years

Individual: 32 Years

  Professional Background
  1. Teaching Experience
  1. Faculty at University of Kashmir, Srinagar, Jammu & Kashmir
    • Lecturer (Hony.) October 1986 – February 1987
  2. Faculty at Academy of Medical Sciences, V. L. College of Pharmacy, Raichur, Karnataka
    • Lecturer August 1987 – July 1988
  3. Faculty at Patliputra College of Pharmacy, Patna, Bihar
    • Assistant Professor August 1988 – December 1988
  4. Faculty at B.I.T., Mesra, Jharkhand
    • Research Associate July 1990 – May 1994
    • Associate Lecturer May 1994 – March 1995
    • Assistant Professor April 1995 – June 2003
    • Senior Lecturer July 2003 – May 2007
    • Lecturer (Selection Grade) June 2007 – February 2009
    • Re-designated as Reader March 2009 – May 2010
    • Associate Professor June 2010 – May 2016
    • Professor June 2016 – Till date
  Research Areas
 

1. Pharmaceutical Chemistry

2. Synthetic Organic Chemisty

3. Natural Product Chemistry

4. Computer Aided Drug Design

  Award and Honours
 

1. Best paper award in National Seminar on Recent trends in Drug Discovery, Bilaspur, 2008.

2. Best paper award in Eastern Regional Conference, Indian Pharmacological Society, Ranchi, 2008. 

   Publications
 
  1. International Journals
  1. Sanduja, M., Gupta, J., Rawat, R., Singh, U., Verma, S. M. Designing, molecular docking, and dynamics simulations studies of 1,2,3-triazole clamped Uracil–Coumarin hybrids against EGFR tyrosine kinase. J. Appl. Pharm. Sci. 2020, 10(03), 001-011. [Impact Factor: 0.533]
  2. Rawat R., Verma, S. M. An exclusive computational insight toward molecular mechanism of MMV007571, a multitarget inhibitor of Plasmodium falciparum. J. Biomol. Struct. Dyn. 2019, 9, 1-12. [Impact Factor: 3.310]
  3. Rawat, P., Verma, S. M., Kumar, P. Novel Chroman Analogs as Promising Heterocyclic Compounds: Their Synthesis and Antiepileptic Activity. Indian J. Pharm. Educ. 2019, 53(4s), 655-665. [Impact Factor: 0.169]
  4. Chakraborty, T., Verma S. M. In silico Analysis and Molecular Docking Studies of Prospective N-Substituted Benzimidazole Hydrazide Analogues for Anticancer Activity. AJBPR. 2018, Special Issue, 112-116.
  5. Vats, P., Monif, T., Verma, S. M. Novel LC-MS/MS Method for Estimation of Niacin with negligible Matrix Effect and its Application to the BE Study. J. Pharm. Investig. 2017, 47(3), 241-248.
  6. Vats, P., Monif, T., Verma, S. M. Mechanistic Evaluation of Matrix Effect on Three Differet Model of Mass Spectrometer by using a Model Drug. J. Analyt. Bioanalyt. Tech. 2016, 7:3. [Impact Factor: 3.307]
  7. Rawat, P., Verma, S. M. Synthesis and Pharmacological Evaluation of 6-hydroxy-2,5,7,8-tetramethyl-N’-(2-oxoindolin-3-ylidene)chroman-2-carbohydrazide Derivatives as Antimicrobial Agents. J. Chem. Pharm. Res. 2016, 8(3), 149-154.
  8. Partani, P., Monif, T., Verma, S. M. Development and Validation of an LC-MS/MS Method for the Determination of Simvastatin and its Active Metabolite, Simvastatin Acid, in Human Plasma and its Application to Pharmacokinetic Study. J. Chromatogr. Sci. 2016, DOI: 10.1093/chromsci/bmw087. [Impact Factor: 1.363]
  9. Rawat, P., Verma, S. M.  Design and Synthesis of Chroman Derivatives with Dual Anti-breast Cancer and Anti-epileptic Activities. Drug. Des. Dev. Ther. 2016, 10, 2779-2788. [Impact Factor: 2.935]
  10. Singh, N., Singh, S. K., Verma, P. R. P., Verma, S. M. Evidence from Bacterial Activities of Lipidic Nanoemulsions against Pseudomonas aeruginosa. Anton. Leeuw. Int. 2015, 107(6), 1555-1568. [Impact Factor: 2.2]
  11. Vats, P. Verma, S. M. Khuroo, A. Monif, T. Effects of Sample Processing Techniques and Instrument Model on Matrix Effect in LC-MS/MS for a Model Drug. J. Liq. Chromatogr. Relat. Technol. 2015, 38(13), 1315-1323. [Impact Factor: 0.64]
  12. Singh, N., Verma, S. M. Antibacterial Screening and Optimization of Lipids for the Preparation of Nanoemulsions. Research Journal of Pharmacy and Technology. 2015, 8(6), 713-718.
  13. Kumari, V. Verma, S. M. Synthesis of 8-azabicyclo[3.2.1]octanes derivatives and its docking study on 2A79, 3G90 and 1FF4. Indo Am. J. Pharm. 2015, 5(7), 2484-2496. [Impact Factor: 3.6]
  14. Rawat, P., Verma, S. M. Docking Studies of Substituted Chroman Analogs at Estrogen Receptor. Asian J. Pharm. Clin. Res. 2015, 8(6), 1-5.
  15. Partani, P., Verma, S. M., Monif, T. Liquid Chromatography Tandem Mass Spectrometry Method for the quantitation of Mycophenolate Mofetil in Human Plasma: Application to a Bioequivalence study and Metabolite identification. Journal of Separation Science. 2015, 38(20), 3533-3544. [Impact Factor: 2.737]
  16. Singh, N., Verma, S.M., Singh, S. K., Verma, P. R. P. Consequences of Lipidic Nanoemulsions on Morphology and Membrane Integrity of Staphylococcus aureus using Transmission Electron Microscopy, Scanning Electron Microscopy and Atomic Force Microscopy. Material Research Express. 2014, 1(2), 1-23. [Impact Factor: 1.151]
  17. Sethi, K. K., Verma, S. M. A Systematic Quantitative Approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors. Journal of Enzyme Inhibition & Medicinal Chemistry. 2014, 29(4), 571-581. [Impact Factor: 2.332]
  18. Partani, P., Verma, S. M., Gurule, S., Khuroo, A., Monif, T. Simultaneous Quantitation of Atorvastatin and its two active metabolites in human plasma by liquid chromatography/ electrospray tandem mass spectrometry. Journal of Pharmaceutical Analysis. 2014, 4(1), 26-36. [Impact Factor: 1.780]
  19. Patel, B., Verma, S. M., Sethi, K. K. 3D-QSAR and Docking studies of N-hydroxy-1,8-naphthyridin-2-one analogues as Ribonuclease H Inhibitors. Letters in Drug Design & Discovery. 2013, 10(9), 823-835. [Impact Factor: 0.872]
  20. Sethi, K. K., Verma, S. M. Pharmacophore modelling and 3D QSAR studies of novel human carbonic anhydrase IX inhibitors. Letters in Drug Design & Discovery. 2013, 10(9). 808-816. [Impact Factor: 0.872]
  21. Sethi, K. K., Verma, S. M., Tanc, M., Carta, F., Supuran C. T. Carbonic anhydrase inhibitors: Synthesis and Inhibition of cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide. Bioorganic & Medicinal Chemistry. 2013, 21(17), 5168-5174. [Impact Factor: 2.793]
  22. Sethi, K. K., Vullo, D., Verma, S. M. Tanc, M., Carta, F., Supuran, C. T. Carbonic anhydrase inhibitors: Synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX, XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalic anhydride moiety. Bioorganic & Medicinal Chemistry. 2013, 21, 5973-5982. [Impact Factor: 2.793]
  23. Behera, P. C., Verma, S. M., Kumar, P. M., Das, N. B., Mishra, P. M., Baliarsingh, S. Anti-inflammatory and Anti-microbial activity of chalcone from Dalbergia Sissoo Roxb. Leaves. American Journal of Phytomedicine and Clinical Therapeutic. 2013, 1, 186-194. [Impact Factor: 1.15]
  24. Singh, N., Verma, S. M., Singh, S. K., Verma, P. R. P., Ahsan, M. N. Antibacterial activity of cationised and non-cationised placebo lipidic nanoemulsion using transmission electron microscopy. Journal of Experimental Nanoscience. 2013, 10(4), 299-309. [Impact Factor: 0.875]
  25. Singh, N., Verma, S. M., Singh, S. K., Verma, P. R. P., Ahsan, M. N. Antibacterial action of lipidic nanoemulsions using atomic force microscopy and scanning electron microscopy on Escherichia coli. Journal of Experimental Nanoscience. 2013, 10(5), 381-391. [Impact Factor: 1.04]
  26. Dadheech M., Verma, S. M., Meena, R. P. Design and Synthesis of some Benzthiazole analogs as A2A receptor antagonists. Journal of Pharm. Sci. Tech. 2012, 4, 873-882. [Impact Factor: 2.451]
  27. Verma, S. M., Diwan, M., Kumari, B. Design, Synthesis and Evaluation of some benzthiazole thiosemicarbazone as Antimicrobial Agents. International journal of Drug Design & Discovery. 2012, 3, 766-771.
  28. Verma, S. M., Saha, A. Mishra, R., Sethi, K. K. 3D-QSAR study of some heterocyclic sulfonamide analogs as Hcaii inhibitors. Letters in Drug Design & Discovery. 2012, 9, 581-586.
  29. Sethi, K. K., Verma, S. M., Kumar, P. M., Mishra, R., Supuran, C. T. Carbonic anhydrase I and II inhibition with natural products:  Leucas Cephalotus. Pharmacognosy Communications. 2011, 1(2), 40-45.
  30. Sethi, K. K., Verma, S. M., Prasanthi, N., Annapurna, M. M., Synthesis, neurotoxicity and Anticonvulsant Study of Some Benzthiazole Analogs. Letters in Drug Design & Discovery. 2011, 8, 774-777. [Impact Factor: 0.845]
  31. Sethi, K. K., Verma, S. M., Pichikalal, J. N., Suresh, P. Synthesis and Study of Antiparkinsonism Activity of 8-azabicyclo[3.2.1]octane analogs. Pharmacology & Pharmacy. 2011, 2, 94-99.
  32. Verma, S. M., Suresh, K. B., Verma, A. Antidiabetic Activity of Leaves of Indigofera Tinctoria Linn. (Fabacaeae). International Journal of Toxicological and Pharmacological Research. 2010, 1(2), 2.
  33. Verma, S. M., Sethi, K. K., Prasanthi, N., Sahoo, S. K., Parhi, R. N., Suresh, P. 3D-QSAR study of Benzene Sulfonamide Anlogs as Carbonic Anhydrase II Inhibitos. Bioorganic & Medicinal Chemistry Letters. 2010, 20, 3089-3093. [Impact Factor: 2.338]
  34. Verma, S. M., Sharon, A., Aggarwal, K., Ghatol, S. P. Pharmacophore distance mapping and docking study of some benzimidazole analogs as A2A Receptor Antagonist. Int. J. Pharm. Sci. Drug. Res. 2010, 2, 71-77.
  35. Verma, S. M., Kumar, S. K. Sedative/hypnotic, Anticonvulsant and Anti-microbial studies on Calotropis gigantea leaf extracts. Hamdard Medicus. 2010, 53(3), 87-89.
  36. Verma, S. M., Razdan, B. K., Sasmal, D. 3D-QSAR study of 8-azabicyclo[3.2.1]octane analogs antagonists cholinergic receptor. Bioorganic & Medicinal Chemistry Letters. 2009, 19, 3108-3112. [Impact Factor: 2.338]
  37. Verma, S. M., Dewangan, P., Basu, A., Venkateshan, J. Multidimensional consensus QSAR: A step towards integrating CoMFA, CoMSIA with traditional QSAR methodologies. Letters in Drug Design and Discovery. 2008, 5, 494-502. [Impact Factor: 0.845]
  38. Verma, S. M., Gunakunru, A. Quantitative Structure Activity Relationship of Riluzole Series as Anticonvusants. Asian Journal of Chemistry. An International Bimonthly Research Journal of Chemistry. 2007, 19(4), 2843-2849.
  Member of Professional Bodies
 

(a). Life Member:

1. Indian Pharmaceutical Association (IPA)

2. Indian Pharmacy Graduates' Association (IPGA)

3. Indian Society for Technical Education (ISTE)

4. Pharmaceutical Society, B.I.T., Mesra, Ranchi

(b). Registered Pharmacist

1. Pharmacy Council of India

(c). Executive Council Member

1. IPA, Jharkhand Branch

  Current Sponsored Projects
 
As Co-investigator:
 

Sl. No.

Title of Project

Funding Agency

Amount

Sanctioned

Status

1.

 

 

 2.

 

 

3.    

 

 

4.       

Design and Evaluation of Transdermal Drug Delivery of Selected Drug

Transdermal Delivery of Selected Drugs: Design, In-vitro and In-vivo Evaluation

Design, Development and Optimization of Self Nanoemulsifying and Solidified Self Nanoemulsifying Drug Delivery Systems of Anti-tubercular Drugs

 

Design of Selective Plasmodium falciparum dihydroorotate dehydrogenase Inhibitors for Anti-malarial Activity

AICTE (TAPTEC)

 

U G C -MRP

 

 

DBT

 

 

 

AICTE RPS-NDF

Rs. 10.00 lacs

 

 

Rs. 7.08 lacs

 

 

Rs. 14.494

lacs

 

Rs. 5 lacs

Completed

(2005)

 

Completed

(2007)

 

 
Completed
(2012)
 
 
 
(Ongoing-till 2021)

 

 

 

  Patent
 
  1. Kalyan K. Sethi, Sourav M. Verma. 4,5,6,7-tetrabromo-1,3-dioxoisoindolin-2-yl benzenesulfonamide derivatives. Ref. no.: E-2/2087/2013-KOL, Application no.: 567/KOL/2013. Indian Patent office, at Kolkata, India. (Complete Specification)
  Fellow
 

1. Fellow of Institution of Chemist (FIC)

2. Fellow of Indian Chemical Society (FICS)